I am a UK-trained consultant ophthalmic surgeon (eye doctor) based in Limassol, Cyprus. My main areas of expertise are medical and surgical retinal disease and cataract surgery. The aim of the clinic I have set up in Limassol is to provide excellence in the management of Retinal Disease and Cataract and providing the same level of care as any specialist retinal/cataract clinic in the UK or USA.

Apart from the clinical aspect of the consultation, it is important to establish effective communication so that patients can be well informed, able to make informed choices and become involved in management decisions. This is key in maintaining good clinical practice, especially for patients suffering with chronic disease.

The clinic has all the state of the art diagnostic equipment for delivering a specialist retinal and cataract service. Surgical procedures take place at Ygeia Polyclinic in Limassol, which is the largest and best equipped private hospital in Cyprus. 


Clinical Expertiese:

As an ophthalmic vitreoretinal surgeon, my areas of subspecialist expertise are Retinal Disease, Eye Trauma and dealing with referred complications of cataract surgery. Having many years of clinical and surgical experience at a major UK tertiary referral centre, I can offer the same level of expertise as a major retinal unit in the UK or USA. Examples of common retinal diseases include Diabetic Retinopathy, Macular Degeneration, Retinal Detachment and Macular Surgery. The clinic has the top of the range equipment for retinal "OCT" scan as well as scanning laser angiography. For retinal laser, I use the latest micropulsed yellow laser, which provides improved results in the management of diabetic retinopathy.

As a cataract surgeon, I have performed thousands of cataract operations and I routinely accept referrals of patients that are at high risk of complications and only eyed patients. I also perform cataract surgery on routine cases. The aim of cataract surgery is to restore vision with the lowest possible risk. In many cases, patients may benefit from novel lens implant technology, which for example allows both distance and near vision without glasses or eliminates astigmatism. Lens implant choice as well surgical planning is a customised process so patients can be advised as to which choices would be appropriate for their particular case.

As a fully qualified and UK trained consultant ophthalmic surgeon, I have considerable clinical experience in managing conditions such as Glaucoma, Corneal Disease and Neuroophthalmology.

Current Appointments:

Consultant Ophthalmic Vitreoretinal Surgeon - Vitreous Retina Macula Clinic, Limassol

Research Fellow, Academic Department of Ophthalmology, University of Bristol

Past Appointments:

Consultant Ophthalmic Vitreoretinal Surgeon - Bristol Eye Hospital

Vitreoretinal Fellow - Bristol Eye Hospital

Specialist Registrar in Ophthalmology - Bristol Eye Hospital - Higher Surgical Training Rotation

Senior House Officer in Ophthalmology - St Thomas' Hospital, London - Surgical Training Rotation

House Officer in Medicine and Surgery - Royal London Hospital

Academic Background:

Certificate of Completion of Fellowship (University of Bristol) - 2010

Certificate of Completion of Specialist Training (General Medical Council, UK) - 2010

                                                                        on the Specialist Register (UK)

Fellowship of the Royal College of Ophthalmologists, London - 2010

Membership of the Royal College of Ophthalmologists, London - 2005

Bachelor of Medicine and Bachelor of Surgery - Royal London Hospital, University of London - 2002

Bachelor of Science (First Class Honours) - UCL, University of London 1999

Prizes and Distinctions:

First Prize Winner - Duke Elder Prize in Ophthalmology, Royal College of Ophthalmologists

Ernest Withers Prize in Ophthalmology

Sir George Burrows Prize in Pathology

Walsham Prize in Surgical Pathology

Riddoch Fears Prize in Neurology (Joint)

Sydney Scott Prize in Ear Nose Throat Surgery

Zeneca 2nd Prize in Pharmacology

Distinction in Pathology

Distinction in Clinical Pharmacology

Distinction in Medicine

Distinction in Surgery

Tumour Biology -  UCL Department of Surgery Research Prize

Peer Reviewer:
Ophthalmology: The official journal of the American Academy of Ophthalmology

Journal of Cataract and Refractive Surgery: The official journal of the American and European Societies of Cataract and Refractive Surgeons

Investigative Ophthalmology and Visual Science

British Journal of Ophthalmology

British Medical Journal

Publications in Academic Journals:

1. MacVie O, Garrott H, Aristodemou P, Harrad R. 2-0 Prolene brow suspension for paediatric ptosis: a retrospective 
case series of 37 eyes. Orbit. 2013 Feb;32(1):16-9. PubMed PMID: 23387449. 
2. Aristodemou P, Stylianides AC. Retinal detachment and fluoroquinolones. JAMA. 2012; 18;308(3):234; author 
reply 235 -6. doi: 10.1001/jama.2012.6618. PubMed PMID: 22797630.

3. Aristodemou P, Knox Cartwright NE, Sparrow JM, Johnston RL. First eye prediction error improves second eye 
refractive outcome results in 2129 patients after bilateral sequential cataract surgery. Ophthalmology. 2011;118(9):
1701-9. PubMed PMID: 21762991.

4. Aristodemou P, Cartwright NK, Sparrow JM, Johnston R. Intraocular lens calculations. Ophthalmology 2011;118(6): 1221. PubMed PMID: 21640267

5. Knox Cartwright NE, Aristodemou P, Sparrow JM, Johnston RL. Adjustment of intraocular lens power for sulcus implantation. Journal of Cataract and Refractive Surgery . 2011;37(4):798-9; author reply 799-800. PubMed PMID: 21420623.

6. Aristodemou P, Knox Cartwright NE, Sparrow JM, Johnston RL. Formula choice: Hoffer Q, Holladay 1, or SRK/T and refractive outcomes in 8108 eyes after cataract surgery with biometry by partial coherence interferometry. Journal of Cataract and Refractive Surgery. 2011;37(1): 63-71. PubMed PMID: 21183100.

7. Aristodemou P, Knox Cartwright NE, Sparrow JM, Johnston RL. Intraocular lens formula constant optimization and partial coherence interferometry biometry: Refractive outcomes in 8108 eyes after cataract surgery. Journal of Cataract and Refractive Surgery. 2011;37(1):50-62. PubMedPMID: 21183099.

8. Aristodemou P, Cartwright NK, Johnston R. Lack of statistical power and refractive outcomes. Invest Ophthalmol Vis Sci. 2010;51(12):6892-3. PubMed PMID: 21123775.

9. Aristodemou P, Knox Cartwright NE, Sparrow JM, Johnston RL. Biometry formula choice and cataract refractive outcomes. Clin Experiment Ophthalmol. 2010;38(5):536-7; author reply 537-8. PubMed PMID: 20649619.

10. Aristodemou P. Lacrimal gland tumor outcomes. Ophthalmology. 2010;117(1):196. PubMed PMID: 20114119.

11. Garrott H, Aristodemou P, Sinclair N, Lane C, Harrad R. Long-term efficacy of 2-0 Prolene brow suspensions for congenital ptosis. Eye (Lond). 2010;24(1):175-7. Epub 2009 Oct 9. PubMed PMID: 19816518.

12: Aristodemou P. Comment on Central retinal artery and vein collapse pressure in giant cell arteritis vs non-arteritic anterior ischaemic optic neuropathy. Eye (Lond). 2009;23(5):1241; author reply 1241-2. Epub 2008 Jun 13. PubMed PMID: 18551138.

13: Aristodemou P, Baer R. Reversible cicatricial ectropion precipitated by topical brimonidine eye drops. Ophthalmic Plastic Reconstructive Surgery 2008;24(1):57-8. PubMed PMID: 18209648.

14: Aristodemou P, Stanford M. Therapy insight: The recognition and treatment of retinal manifestations of systemic vasculitis. Nature Clinical Practice Rheumatology. 2006;2(8):443-51. Review. PubMed PMID: 16932736.

15: Aristodemou P, Membrey L. Retinal detachments are not always preceded by flashing lights or floaters. British Medical Journal 2006; 333(7563): 360
 16:  Aristodemou P, Stanford MR. The assessment of acute
anterior uveitis in primary care. Clinical Focus 

17: Aristodemou P, Watt L, Baldwin C, Hugkulstone C. Diplopia associated with the cosmetic use of botulinum toxin a for facial rejuvenation. Ophthalmic Plastic Reconstructive Surgery. 2006;22(2):134-6. PubMed PMID: 16550061.

18: Myatt N, Aristodemou P, Neale MH, Foss AJ, Hungerford JL, Bhattacharya S, A Cree I. Abnormalities of the transforming  growth factor-beta pathway in ocular melanoma. Journal of Pathology. 2000;192(4):511-8. PubMed PMID: 11113869.

Academic Presentations in National and International Meetings

1. Knox-Cartwright NE, Aristodemou P, Johnston RL. Optimisation of IOL power calculations constants: by unit or by surgeon? UK and Ireland Society of Cataract and Refractive Surgery, 2009.   

Winner for best Poster and the Founders Medal for Best Overall Paper

 2. Knox-Cartwright NE,
Aristodemou P, Johnston RL. Adjusting for first eye
prediction error improves refractive outcomes of second eye cataract surgery UK
and Ireland Society of Cataract and Refractive Surgery, 2009

3. Knox-Cartwright NE, Aristodemou P, Sparrow JM, Johnston RL. Optimization of IOL Power Calculation Constants: By Unit or by Surgeon? Scientific Poster at the American Academy of Ophthalmology meeting , San Francisco 2009

4. Garrott H, Aristodemou P, Harrad RA. Unexpected prolonged duration of effect of 2-0 prolene brow suspensions in paediatric ptosis. 2009 Congress of the Royal College of Ophthalmologists.

5. Aristodemou P, Connell P, Romeo G, Haynes RJ. Radial extension of retinal break to the optic nerve associated with 4% Pilocarpine. British and Eire Association of Vitreoretinal Surgeons meeting, Reading 2008

6. Carter JG, Aristodemou P, Cherry J, Churchill AJ. DNA profile strongly associated with exudative age-related macular degeneration. Presented at the European Association for Vision and Eye Research (EVER) Annual Congress 2008, Program No. 6354, Saturday, 4th of October [www.ever.be].

7. Aristodemou P, Luck J. Rescuing the Running Rhexis: The restoration of the direction of a continuous circular capsulorhexis when the rhexis “runs out”. Free paper presentation. XXIV Congress of the European Society of Cataract and Refractive Surgery, London. 12th September 2006.